secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2025-05-07T23:59:59+00:00
Accession:  0000950170-25-065655
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RxSight Q1 revenue $37.9M (+28% YoY); LAL volume up 36%
-------------------------------------------------------

- Q1 revenue $37.9M (+28% YoY); LAL revenue +37%, LDD revenue +8%.
- Net loss $(8.2M) or $(0.20)/share; adjusted net loss $(1.1M) or $(0.03)/share.
- 27,579 LALs sold (+36% YoY); 73 LDDs; installed base 1,044 (+43% YoY).
- Gross margin 74.8% vs 70.1% YoY; cash $229.3M at quarter end.
- Reiterated FY2025 guidance: revenue $160-175M, GM 71-73%, OpEx $150-160M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000095017025065655/0000950170-25-065655-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000095017025065655/rxst-20250507.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-065655

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer